medRxiv 预印本· Pailler-Pradeau, C., Lemee, M. V., Cevallos, C., Mattioli, F., Chrast, J., Bassani, S., Darvish, H., Zanni, G., Colafati, G. S., Travaglini, L., Nicita, F., Amudhavalli, S. M., Lawson, C., Gleeson, J. G., Stuewe, I., Friedman, L., Zaki, M. S., Bell, L., Boucher Brischoux, E., Kuentz, P., Fuhrmann, N., Lampkemeyer, V., Netzer, C., Smol, T., Vincent-Delorme, C., Iqbal, Z., Toft, M., Zehra, T., Jafri, S. K., Fatima, A., Ullah, M., Akhtar, Z., Shan, T., Firasat, S., Firouzabadi, S. G., Tafakhori, A., Sharbatkhori, S., Jamali, F., Balbach, M., Hildebrandt, F., O'Heir, E., Pais, L., Sanchis-Juan, A. ·· 2026-09-30AI 评分22
CSMD2 单倍剂量不足、de novo 及双等位基因错义变异与神经发育障碍相关
Haploinsufficiency, de novo and biallelic missense variants in CSMD2 are associated with neurodevelopmental disorders
AI 导读
研究在发育迟缓/智力障碍队列中鉴定出8个家系9例携带CSMD2双等位基因错义变异的个体,表现为自闭症谱系障碍、ADHD及脑结构异常。另报告2个家系分离单等位基因CSMD2移码变异,并发现2例de novo错义变异个体;UK Biobank分析显示携带至少一个罕见CSMD2变异的志愿者中ADHD、ASD和神经质呈名义显著富集。
来源:medRxiv 预印本 · medrxiv.org